167 related articles for article (PubMed ID: 1372102)
1. Three nonsense mutations responsible for group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
[TBL] [Abstract][Full Text] [Related]
2. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212
[TBL] [Abstract][Full Text] [Related]
3. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
Satokata I; Tanaka K; Yuba S; Okada Y
Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a splicing mutation in group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Miyamoto I; Satoh Y; Kondo S; Okada Y
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9908-12. PubMed ID: 1702221
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
[TBL] [Abstract][Full Text] [Related]
7. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T; Tanaka K; Nagai A; Mino M
Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
[TBL] [Abstract][Full Text] [Related]
8. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
J Invest Dermatol; 1997 Sep; 109(3):306-9. PubMed ID: 9284095
[TBL] [Abstract][Full Text] [Related]
9. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
10. DNA-based prenatal carrier detection for group A xeroderma pigmentosum in a chorionic villus sample.
Matsumoto N; Saito N; Harada N; Tanaka K; Niikawa N
Prenat Diagn; 1995 Jul; 15(7):675-7. PubMed ID: 8532631
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of group A xeroderma pigmentosum: a missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene.
Satokata I; Tanaka K; Okada Y
Hum Genet; 1992 Mar; 88(6):603-7. PubMed ID: 1339397
[TBL] [Abstract][Full Text] [Related]
12. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
[TBL] [Abstract][Full Text] [Related]
13. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
15. Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
Clin Genet; 1995 Nov; 48(5):225-31. PubMed ID: 8825598
[TBL] [Abstract][Full Text] [Related]
16. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
18. Allelic heterogeneity in group A xeroderma pigmentosum.
Mimaki T; Tanaka K; Okada Y; Minami R; Tachi N; Nagai A; Mino M
Acta Neurol Scand; 1992 May; 85(5):327-30. PubMed ID: 1621494
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene.
Jones CJ; Lloyd RS; Wood RD
Mutat Res; 1994 Aug; 324(4):159-64. PubMed ID: 7519740
[TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
